The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024: Featured Updates to the NCCN Guidelines
Open accessAbstract
The NCCN Guidelines for Cervical Cancer provide recommendations for all aspects of management for cervical cancer, including the diagnostic workup, staging, pathology, and treatment. The guidelines also include details on histopathologic classification of cervical cancer regarding diagnostic features, molecular profiles, and clinical outcomes. The treatment landscape of advanced cervical cancer is evolving constantly. These NCCN Guidelines Insights provide a summary of recent updates regarding the systemic therapy recommendations for recurrent or metastatic disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kamangar, F., Dores, G. M., & Anderson, W. F. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.2308 · Cited by 3,434
Marabelle, A., Le, D. T., Ascierto, P. A., Di Giacomo, A. M., De Jesus-Acosta, A., Delord, J.-P., Geva, R., Gottfried, M., Penel, N., Hansen, A. R., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.02105 · Cited by 3,048
Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
Rose, P. G., Bundy, B. N., Watkins, E. B., Thigpen, J. T., Deppe, G., Maiman, M. A., Clarke-Pearson, D. L., & Insalaco, S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904153401502 · Cited by 2,658
Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis
de Martel, C., Georges, D., Bray, F., Ferlay, J., & Clifford, G. M. (2020) · The Lancet Global Health · doi:10.1016/s2214-109x(19)30488-7 · Cited by 2,475
Morris, M., Eifel, P. J., Lu, J., Grigsby, P. W., Levenback, C., Stevens, R. E., Rotman, M., Gershenson, D. M., & Mutch, D. G. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904153401501 · Cited by 2,299
Self-citationKeys, H. M., Bundy, B. N., Stehman, F. B., Muderspach, L. I., Chafe, W. E., Suggs, C. L., Walker, J. L., & Gersell, D. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904153401503 · Cited by 1,923
Doebele, R. C., Drilon, A., Paz-Ares, L., Siena, S., Shaw, A. T., Farago, A. F., Blakely, C. M., Seto, T., Cho, B. C., Tosi, D., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30691-6 · Cited by 1,790
Whitney, C. W., Sause, W., Bundy, B. N., Malfetano, J. H., Hannigan, E. V., Fowler, Jr., Clarke-Pearson, D. L., & Liao, S.-Y. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.5.1339 · Cited by 1,524
Meric-Bernstam, F., Makker, V., Oaknin, A., Oh, D.-Y., Banerjee, S., González-Martín, A., Jung, K. H., Ługowska, I., Manso, L., Manzano, A., et al. (2024) · Journal of Clinical Oncology · doi:10.1200/jco.23.02005 · Cited by 1,069
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer
Colombo, N., Dubot, C., Lorusso, D., Caceres, M. V., Hasegawa, K., Shapira-Frommer, R., Tewari, K. S., Salman, P., Hoyos Usta, E., Yañez, E., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2112435 · Cited by 1,067
Hong, D. S., DuBois, S. G., Kummar, S., Farago, A. F., Albert, C. M., Rohrberg, K. S., van Tilburg, C. M., Nagasubramanian, R., Berlin, J. D., Federman, N., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30856-3 · Cited by 1,028
Eifel, P. J., Winter, K., Morris, M., Levenback, C., Grigsby, P. W., Cooper, J., Rotman, M., Gershenson, D., & Mutch, D. G. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.07.197 · Cited by 1,018
Self-citationCarcinogenic human papillomavirus infection
Schiffman, M., Doorbar, J., Wentzensen, N., de Sanjosé, S., Fakhry, C., Monk, B. J., Stanley, M. A., & Franceschi, S. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.86 · Cited by 999
Monk, B. J., Sill, M. W., McMeekin, D. S., Cohn, D. E., Ramondetta, L. M., Boardman, C. H., Benda, J., & Cella, D. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.21.8909 · Cited by 693
Castellsagué, X., Díaz, M., de Sanjosé, S., Muñoz, N., Herrero, R., Franceschi, S., Peeling, R. W., Ashley, R., Smith, J. S., Snijders, P. J. F., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj067 · Cited by 688
Tewari, K. S., Sill, M. W., Penson, R. T., Huang, H., Ramondetta, L. M., Landrum, L. M., Oaknin, A., Reid, T. J., Leitao, M. M., Michael, H. E., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31607-0 · Cited by 684
Moore, D. H., Blessing, J. A., McQuellon, R. P., Thaler, H. T., Cella, D., Benda, J., Miller, D. S., Olt, G., King, S., Boggess, J. F., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.04.170 · Cited by 635
Kjaer, S. K., Frederiksen, K., Munk, C., & Iftner, T. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq356 · Cited by 579
Long, H. J., Bundy, B. N., Grendys, E. C., Benda, J. A., McMeekin, D. S., Sorosky, J., Miller, D. S., Eaton, L. A., & Fiorica, J. V. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.10.021 · Cited by 556
Frenel, J.-S., Le Tourneau, C., O’Neil, B., Ott, P. A., Piha-Paul, S. A., Gomez-Roca, C., van Brummelen, E. M. J., Rugo, H. S., Thomas, S., Saraf, S., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.74.5471 · Cited by 531
HER2 expression status in diverse cancers: review of results from 37,992 patients
Yan, M., Schwaederle, M., Arguello, D., Millis, S. Z., Gatalica, Z., & Kurzrock, R. (2015) · Cancer and Metastasis Reviews · doi:10.1007/s10555-015-9552-6 · Cited by 483
Maio, M., Ascierto, P. A., Manzyuk, L., Motola-Kuba, D., Penel, N., Cassier, P. A., Bariani, G. M., De Jesus Acosta, A., Doi, T., Longo, F., et al. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2022.05.519 · Cited by 472
Subbiah, V., Wolf, J., Konda, B., Kang, H., Spira, A., Weiss, J., Takeda, M., Ohe, Y., Khan, S., Ohashi, K., et al. (2022) · The Lancet Oncology · doi:10.1016/s1470-2045(22)00541-1 · Cited by 449
Wang, S. S., Sherman, M. E., Hildesheim, A., Lacey, J. V., & Devesa, S. (2004) · Cancer · doi:10.1002/cncr.20064 · Cited by 442
Naumann, R. W., Hollebecque, A., Meyer, T., Devlin, M.-J., Oaknin, A., Kerger, J., López-Picazo, J. M., Machiels, J.-P., Delord, J.-P., Evans, T. R. J., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.19.00739 · Cited by 440
Howe, H. L., Wu, X., Ries, L. A. G., Cokkinides, V., Ahmed, F., Jemal, A., Miller, B., Williams, M., Ward, E., Wingo, P. A., et al. (2006) · Cancer · doi:10.1002/cncr.22193 · Cited by 427
Coleman, R. L., Lorusso, D., Gennigens, C., González-Martín, A., Randall, L., Cibula, D., Lund, B., Woelber, L., Pignata, S., Forget, F., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00056-5 · Cited by 410
Incidence Trends of Adenocarcinoma of the Cervix in 13 European Countries
Bray, F., Carstensen, B., Møller, H., Zappa, M., Žakelj, M. P., Lawrence, G., Hakama, M., & Weiderpass, E. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0231 · Cited by 393
Bray, F., Loos, A. H., McCarron, P., Weiderpass, E., Arbyn, M., Møller, H., Hakama, M., & Parkin, D. M. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0569 · Cited by 370
Rose, P. G., Ali, S., Watkins, E., Thigpen, J. T., Deppe, G., Clarke-Pearson, D. L., & Insalaco, S. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.4532 · Cited by 284
de Bono, J. S., Concin, N., Hong, D. S., Thistlethwaite, F. C., Machiels, J.-P., Arkenau, H.-T., Plummer, R., Jones, R. H., Nielsen, D., Windfeld, K., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30859-3 · Cited by 237
Demetri, G. D., De Braud, F., Drilon, A., Siena, S., Patel, M. R., Cho, B. C., Liu, S. V., Ahn, M.-J., Chiu, C.-H., Lin, J. J., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-3597 · Cited by 223
Boussios, S., Seraj, E., Zarkavelis, G., Petrakis, D., Kollas, A., Kafantari, A., Assi, A., Tatsi, K., Pavlidis, N., & Pentheroudakis, G. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2016.11.006 · Cited by 174
Santin, A. D., Deng, W., Frumovitz, M., Buza, N., Bellone, S., Huh, W. K., Khleif, S. N., Lankes, H. A., Ratner, E., O'Cearbhaill, R. E., et al. (2020) · Gynecologic Oncology · doi:10.1016/j.ygyno.2019.12.034 · Cited by 154
Tisotumab Vedotin in Previously Treated Recurrent or Metastatic Cervical Cancer
Hong, D. S., Concin, N., Vergote, I. B., Bono, J. S. D., Slomovitz, B. M., Drew, Y., Arkenau, H., Machiels, J.-P., Spicer, J. F., Jones, R., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-2962 · Cited by 134
Incidence trends of invasive cervical cancer in the United States by combined race and ethnicity
Barnholtz‐Sloan, J. S., Patel, N. N., Rollison, D. E. M., Kortepeter, K., MacKinnon, J., & Giuliano, A. R. (2009) · Cancer Causes & Control · doi:10.1007/s10552-009-9317-z · Cited by 115
Radiosensitizers in cervical cancer. Cisplatin and beyond
Candelaria, M., Garcia-Arias, A., Cetina, L., & Dueñas‐González, A. (2006) · Radiation Oncology · doi:10.1186/1748-717x-1-15 · Cited by 110
Cervical cancer incidence among 6 Asian ethnic groups in the United States, 1996 through 2004
Wang, S., Carreon, J. D., Gomez, S. L., & Devesa, S. S. (2009) · Cancer · doi:10.1002/cncr.24843 · Cited by 81
HER2 expression in cervical cancer as a potential therapeutic target
Chávez-Blanco, A. D., Pérez-Sánchez, V. M., González‐Fierro, A., Vela-Chávez, T., Candelaria, M., Cetina, L., Vidal, S., & Dueñas‐González, A. (2004) · BMC Cancer · doi:10.1186/1471-2407-4-59 · Cited by 69
Rodríguez, A. C., SCHIFFMAN, M. H., Herrero, R., Hildesheim, A., Bratti, C., Sherman, M. E., Solomon, D., Guillén, D., Alfaro, M., Morales, J., et al. (2010) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0b013e3181e5a0ed · Cited by 54
Chemotherapy for recurrent and metastatic cervical cancer
Xia, T., Hu, W., Ramirez, P. T., et al. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.04.024 · Cited by 47
Cocco, E., Varughese, J., Buza, N., Bellone, S., Glasgow, M. A., Bellone, M., Todeschini, P., Carrara, L., Silasi, D.-A., Azodi, M., et al. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-263 · Cited by 47
Itkin, B., Garcia, A., Straminsky, S., Adelchanow, E. D., Pereyra, M. G., Haab, G. A., & Bardach, A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0257976 · Cited by 46
King, M. T., McConkey, C., Latief, T. N., Hartley, A. G. J., & Fernando, I. N. (2005) · Clinical Oncology · doi:10.1016/j.clon.2005.09.001 · Cited by 40
Concurrent 5-fluorouracil, mitomycin C and irradiation in locally advanced cervix cancer
Christie, D., Bull, C. A., Gebski, V., & Langlands, A. O. (1995) · Radiotherapy and Oncology · doi:10.1016/0167-8140(95)01648-1 · Cited by 32
A Review of Tisotumab Vedotin-tftv in Recurrent or Metastatic Cervical Cancer
Heitz, N., Greer, S. C., & Halford, Z. (2022) · Annals of Pharmacotherapy · doi:10.1177/10600280221118370 · Cited by 30
Integrated genomic and molecular characterization of cervical cancer
Burk, R., Chen, Z., Saller, C., et al. (2017) · eScholarship (California Digital Library) · Cited by 24
Vale, C. L., Tierney, J., Stewart, L. A., Brady, M. F., Dinshaw, K., Jakobsen, A., Parmar, M., Thomas, G., Trimble, T., Alberts, D., et al. (2008) · UCL Discovery (University College London) · Cited by 15
Cai, Z., Yang, H., Huang, T. H., Yu, Z., Ren, N., Su, J., Lin, X., & Zhou, H. (2023) · PubMed Central · Cited by 7
Cited by
Wang, Y., Xu, Y., Song, J., Liu, X., Liu, S., Yang, N., Wang, L., Liu, Y., Zhao, Y., Zhou, W., et al. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s466042 · Cited by 525
Metadata
- Authors
- Abu-Rustum, N. R., Yashar, C. M., Arend, R., Barber, E., Bradley, K., Brooks, R., Campos, S. M., Chino, J., Chon, H. S., Crispens, M. A., Damast, S., Fisher, C. M., Frederick, P., Gaffney, D. K., Gaillard, S., Giuntoli, R., Glaser, S., Holmes, J., Howitt, B. E., Lea, J., Mantia-Smaldone, G., Mariani, A., Mutch, D., Nagel, C., Nekhlyudov, L., Podoll, M., Rodabaugh, K., Salani, R., Schorge, J., Siedel, J., Sisodia, R., Soliman, P., Ueda, S., Urban, R., Wyse, E., McMillian, N. R., Aggarwal, S., & Espinosa, S.
- Venue
- Journal of the National Comprehensive Cancer Network
- Publisher
- Harborside Press, LLC
- Published
- 2023-12
- Volume
- 21
- Issue
- 12
- Pages
- 1224-1233
- ISSN
- 1540-1405 (ISSN-L)
- 1540-1413
- OpenAlex
- W4389538263
- Cited by
- 384
- References
- 49
- FWCI
- 105.10
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.